The University of Chicago Header Logo

Connection

Carla Harmath to Liver Neoplasms

Back to Details
This is a "connection" page, showing publications Carla Harmath has written about Liver Neoplasms.
Carla Harmath
Connection Strength
1.520
Liver Neoplasms
  1. Beyond LI-RADS: Decoding the Prognostic Value of MRI Findings in HCC. Radiology. 2023 04; 307(2):e223309.
    View in: PubMed
    Score: 0.570
  2. HCC: role of pre- and post-treatment tumor biology in driving adverse outcomes and rare responses to therapy. Abdom Radiol (NY). 2021 08; 46(8):3686-3697.
    View in: PubMed
    Score: 0.509
  3. Congestive Hepatopathy: Pathophysiology, Workup, and Imaging Findings with Pathologic Correlation. Radiographics. 2024 May; 44(5):e230121.
    View in: PubMed
    Score: 0.155
  4. Hepatocellular carcinoma: metastatic pathways and extra-hepatic findings. Abdom Radiol (NY). 2021 08; 46(8):3698-3707.
    View in: PubMed
    Score: 0.127
  5. Reproducibility of mRECIST in assessing response to transarterial radioembolization therapy in hepatocellular carcinoma. Hepatology. 2015 Oct; 62(4):1111-21.
    View in: PubMed
    Score: 0.084
  6. Assessment of liver tumor response to therapy: role of quantitative imaging. Radiographics. 2013 Oct; 33(6):1781-800.
    View in: PubMed
    Score: 0.074
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.